BioCentury
ARTICLE | Financial News

AbbVie unveils $1.5B buyback program

February 16, 2013 1:30 AM UTC

AbbVie Inc. (NYSE:ABBV) said its board authorized the repurchase of up to $1.5 billion of the company's stock over a "multi-year period." AbbVie was spun out of Abbott Laboratories Inc. (NYSE:ABT) in ...